Photodiagnosis and Photodynamic Therapy
Volume 7, Issue 1 , Pages 16-23 , March 2010

An overview of topical photodynamic therapy in dermatology

References 

  1. Kennedy JC, Pottier RH, Pross DC. Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experience. J Photochem Photobiol B Biol. 1990;6:143–148
  2. Svanberg K, Andersson T, Killander D, et al. Photodynamic therapy of non-melanoma malignant tumours of the skin using topical δ-aminolevulinic acid sensitization and laser irradiation. Br J Dermatol. 1994;130:743–751
  3. Smits T, van Laarhoven AIM, Staassen A, et al. Induction of protoporphyrin IX by aminolaevulinic acid in actinic keratosis, psoriasis and normal skin: preferential porphyrin enrichment in differentiated cells. Br J Dermatol. 2009;160:849–857
  4. Soler A-M, Angell-Petersen E, Warloe T, et al. Photodynamic therapy of superficial basal cell carcinoma with 5-aminolevulinic acid with dimethylsulfoxide and ethylendiaminetetraacetic acid: a comparison of two light sources. Photochem Photobiol. 2000;71:724–729
  5. Clark C, Bryden A, Dawe RS, et al. Topical 5-aminolaevulinic acid photodynamic therapy for cutaneous lesions: outcome and comparison of light sources. Photodermatol Photoimmmunol Photomed. 2003;19:134–141
  6. Moseley H, Allen JW, Ibbotson SH, et al. Ambulatory photodynamic therapy: a new concept in delivering photodynamic therapy. Br J Dermatol. 2006;154:747–750
  7. Attili SK, Lesar A, McNeill A, et al. An open pilot study of ambulatory photodynamic therapy using a wearable low-irradiance organic light-emitting diode light source in the treatment of nonmelanoma skin cancer. Br J Dermatol. 2009;161:170–173
  8. Babilas P, Knobler R, Hummel S, et al. Variable pulsed light is less painful than light-emitting diodes for topical photodynamic therapy of actinic keratosis: a prospective randomized controlled trial. Br J Dermatol. 2007;157:111–117
  9. Wiegell SR, Haedersdal PA, Philipsen PA, et al. Continuous activation of PpIX by daylight is as effective and less painful than conventional photodynamic therapy for actinic keratoses: a randomized, controlled, single blinded study. Br J Dermatol. 2008;158:740–746
  10. Wiegell SR, Haedersdal , Eriksen P, et al. Photodynamic therapy of actinic keratoses with 8% and 16% methyl aminolaevulinate and home-based daylight exposure: a double blinded randomized clinical trial. Br J Dermatol. 2009;160:1308–1314
  11. Morton C, Brown SB, Collins S, et al. Guidelines for topical photodynamic therapy: report of a workshop of the British Photodermatology Group. Br J Dermatol. 2002;146:552–567
  12. Morton CA, McKenna KE, Rhodes LE, et al. Guidelines for topical photodynamic therapy: update. Br J Dermatol. 2008;159:1245–1266
  13. Braathen LR, Szeimies R-M, Basset-Seguin N, et al. Guidelines on the use of photodynamic therapy for non-melanoma skin cancer: an international consensus. J Am Acad Dermatol. 2007;56:125–143
  14. Calzavara-Pinton PG. Repetitive photodynamic therapy with topical δ-aminolaevulinic acid as an appropriate approach to the routine treatment of superficial non-melanoma skin tumors. J Photochem Photobiol B-Biol. 1995;29:53–57
  15. Tschen EH, Wong DS, Pariser DM, et al. Photodynamic therapy using aminolaevulinic acid for patients with nonhyperkeratotic actinic keratoses of the face and scalp: phase IV multicentre clinical trial with 12-month follow up. Br J Dermatol. 2006;155:1262–1269
  16. Tarstedt M, Rosdahl I, Berne B, et al. A randomized multicenter study to compare two treatment regimens of topical methyl aminolevulinate (Metvix)-PDT in actinic keratosis of the face and scalp. Acta Derm Venereol. 2005;85:424–428
  17. Braathen LR, Paredes BE, Salsela O, et al. Short incubation with methyl aminolevulinate for photodynamic therapy of actinic keratoses. J Euro Acad Dermatol. 2009;23:550–555
  18. Szeimies RM, Karrer S, Radakovic-Fijan S, et al. Photodynamic therapy using topical methyl 5-aminolevulinate compared with cryotherapy for actinic keratosis: a prospective, randomized study. J Am Acad Dermatol. 2002;47:258–262
  19. Freeman M, Vinciullo C, Francis D, et al. A comparison of photodynamic therapy using topical methyl aminolevulinate (Metvix) with single cycle cryotherapy in patients with actinic keratosis: a prospective randomized study. J Dermatol Treat. 2003;14:99–106
  20. Morton C, Campbell S, Gupta G, et al. Intraindividual, right-left comparison of topical methyl aminolaevulinate-photodynamic therapy and cryotherapy in subjects with actinic keratoses: a multicentre, randomized controlled study. Br J Dermatol. 2006;155:1029–1036
  21. Kurwa HA, YoNg-Gee SA, Seed PT, et al. A randomized paired comparison of photodynamic therapy and topical 5-fluorouracil in the treatment of actinic keratoses. J Am Acad Dermatol. 1999;41:414–418
  22. Smith S, Piacquadio D, Morhenn V, et al. Short incubation PDT versus 5-FU in treating actinic keratoses. J Drugs Dermatol. 2003;2:629–635
  23. Sotiriou E, Apalla Z, Maliamani F, et al. Intraindividual, right-left comparison of topical 5-aminolevulinic acid photodynamic therapy vs. 5% imiquimod cream for actinic keratoses on the upper extremities. J Euro Acad Dermatol. 2009;23:1061–1065
  24. Cox NH, Eedy DJ, Morton CA. Guidelines for management of Bowen's disease: 2006 update. Br J Dermatol. 2007;156:11–21
  25. Graham JH, Elson B, Helwig MD. Bowen's disease and its relationship to systemic cancer. Arch Dermatol. 1961;83:738–758
  26. Thestrup-Pedersen K, Ravnborg L, Reymann F. Morbus bowen – a description of the disease in 617 patients. Acta Derm Venereol. 1988;68:236–239
  27. Cox NH, Eedy DJ, Morton CA. Guidelines for management of Bowen's disease. Br J Dermatol. 1999;141:633–641
  28. Lehmann P. Methyl aminolaevulinate-photodynamic therapy: a review of clinical trials in the treatment of actinic keratoses and nonmelanoma skin cancer. Br J Dermatol. 2007;156:793–801
  29. Stables GI, Stringer MR, Robinson DJ, et al. Large patches of Bowen's disease treated by topical aminolaevulinic acid photodynamic therapy. Br J Dermatol. 1997;136:957–960
  30. Morton CA, Whitehurst C, McColl JH, et al. Photodynamic therapy for large or multiple patches of Bowen's disease and basal cell carcinoma. Arch Dermatol. 2001;137:319–324
  31. Togsverd-Bo K, Haedersdal M, Wulf HC. Photodynamic therapy for tumors on the eyelid margins. Arch Dermatol. 2009;145:944–947
  32. Morton CA, Whitehurst C, Moseley H, et al. Comparison of photodynamic therapy with cryotherapy in the treatment of Bowen's disease. Br J Dermatol. 1996;135:766–771
  33. Salim A, Leman JA, McColl JH, et al. Randomized comparison of photodynamic therapy with topical 5-fluorouracil in Bowen's disease. Br J Dermatol. 2003;148:539–543
  34. Morton C, Horn M, Leman J, et al. Comparison of topical methyl aminolevulinate photodynamic therapy with cryotherapy or fluorouracil for treatment of squamous cell carcinoma in situ: results of a multicenter randomized trial. Arch Dermatol. 2006;142:729–735
  35. Wang I, Bendsoe N, Klinteberg CAF, et al. Photodynamic therapy vs. cryotherapy of basal cell carcinoma: results of a phase III clinical trial. Br J Dermatol. 2001;144:832–840
  36. Basset-Seguin N, Ibbotson SH, Emtestam L, et al. Topical methyl aminolaevulinate photodynamic therapy versus cryotherapy for superficial basal cell carcinoma: a 5 year randomized trial. Euro J Dermatol. 2008;18:547–553
  37. Szeimies RM, Ibbotson SH, Murrell DF, et al. A clinical study comparing methyl aminolevulinate photodynamic therapy and surgery in small superficial basal cell carcinoma (8-20mm), with a 12-month follow-up. J Eur Acad Dermatol Venereol. 2008;22:1302–1311
  38. Rhodes LE, de Rie MA, Leifsdottir , et al. Five-year follow-up of a randomized, prospective trial of topical methyl aminolevulinate photodynamic therapy vs surgery for nodular basal cell carcinoma. Arch Dermatol. 2007;143:1131–1136
  39. Berroeta L, Clark C, Dawe RS, et al. A randomized study of minimal curettage followed by topical photodynamic therapy compared with surgical excision for low-risk nodular basal cell carcinoma. Br J Dermatol. 2007;157:401–403
  40. Mosterd K, Thissen MRTM, Nelemans P, et al. Fractionated 5-aminolaevulinic acid-photodynamic therapy vs. surgical excision in the treatment of nodular basal cell carcinoma: results of a randomized controlled trial. Br J Dermatol. 2008;159:864–870
  41. Morton C, MacKie RM, Whitehurst C, et al. Photodynamic therapy for basal cell carcinoma: effect of tumor thickness and duration of photosensitizer application on response. Arch Dermatol. 1998;134:248–249
  42. Soler AM, Warloe T, Tausjo J, et al. Photodynamic therapy by topical aminolevulinic acid, dimethylsulphoxide and curettage in nodular basal cell carcinoma: a one-year follow-up study. Acta Derm Venereol. 1999;79:204–206
  43. Soler AM, Warloe T, Berner A, et al. A follow-up study of recurrence and cosmesis in completely responding superficial and nodular basal cell carcinomas treated with methyl 5-aminolaevulinate-based photodynamic therapy alone and with prior curettage. Br J Dermatol. 2001;145:467–471
  44. Thissen MRTM, Schroeter CA, Neumann HAM. Photodynamic therapy with delta-aminolaevulinic for nodular basal cell carcinoma using a prior debulking technique. Br J Dermatol. 2000;142:338–339
  45. De Haas ERM, De Bruijn HS, Sterenborg HJCM, et al. Microscopic distribution of protoporphyrin IX (PpIX) fluorescence in superficial basal cell carcinoma during light-fractionated aminolaevulinic acid photodynamic therapy. Acta Derm Venereol. 2008;88:547–554
  46. De Haas ERM, de Vijlder HC, Sterenborg HJCM, et al. Fractionated aminolevulinic acid-photodynamic therapy provides additional evidence for the use of PDT for non-melanoma skin cancer. J Euro Acad Dermatol. 2008;22:426–430
  47. Campbell SM, Morton CA, Alyahya R, et al. Clinical investigation of the novel iron-chelating agent, CP94, to enhance topical photodynamic therapy of nodular basal cell carcinoma. Br J Dermatol. 2008;159:387–393
  48. Gerritsen MJ, Smits T, Kleinpenning MM, et al. Pretreatment to enhance protoporphyrin IX accumulation in photodynamic therapy. Dermatology. 2009;218:193–202
  49. Dragieva G, Prinz BM, Hafner J, et al. A randomized controlled clinical trial of topical photodynamic therapy with methyl aminolaevulinate in the treatment of actinic keratoses in transplant recipients. Br J Dermatol. 2004;151:196–200
  50. Piaserico S, Fortina AB, Rigotti P, et al. Topical photodynamic therapy of actinic keratosis in renal transplant recipients. Transplantation Proc. 2007;39:1847–1850
  51. Wulf HC, Pavel S, Stender I, et al. Topical photodynamic therapy for prevention of new skin lesions in renal transplant recipients. Acta Derm Venereol. 2006;86:25–28
  52. De Graaf YGL, Kennedy C, Wolterbeek R, et al. Photodynamic therapy does not prevent cutaneous squamous-cell carcinoma in organ-transplant recipients: results of a randomized-controlled trial. J Invest Dermatol. 2006;126:569–574
  53. Wennberg A-M, Stenquist B, Stockfleth E, et al. Photodynamic therapy with methyl aminolevulinate for prevention of new skin lesions in transplant recipients: a randomized study. Transplantation. 2008;86:423–429
  54. Perrett CM, McGregor JM, Warwick J, et al. Treatment of post-transplantation premalignant skin disease: a randomized intrapatient comparative study of 5-fluorouracil cream and topical photodynamic therapy. Br J Dermatol. 2007;156:320–328
  55. Rud E, Gederaas O, Høgset A, et al. 5-aminolevulinic acid, but not 5-aminolevulinic esters, is transported into adenocarcinoma cells by system BETA transporters. Photochem Photobiol. 2000;71:640–647
  56. Brooke RCC, Sinha A, Sidhu MK, et al. Histamine is released following aminolevulinic acid-photodynamic therapy of human skin and mediates an aminolevulinic acid dose-related immediate inflammatory response. J Invest Dermatol. 2006;126:2296–2301
  57. Ericson MB, Sandberg C, Stenquist B, et al. Photodynamic therapy of actinic keratosis at varying fluence rates: assessment of photobleaching, pain and primary clinical outcome. Br J Dermatol. 2004;151:1204–1212
  58. Grapengiesser S, Gudmundsson O, Larko O, et al. Pain caused by photodynamic therapy of skin cancer. Clin Exp Dermatol. 2002;27:493–497
  59. Sandberg C, Stenquist B, Rosdal I, et al. Important factors for pain during photodynamic therapy for actinic keratosis. Acta Derm-Venereol. 2006;86:404–408
  60. Wiegell SR, Stender I-M, Renhua NA, et al. Pain associated with photodynamic therapy using 5-aminolevulinic acid or 5-aminolevulinic acid methylester on tape-stripped normal skin. Arch Dermatol. 2003;139:1173–1177
  61. Wiegell SR, Skiveren J, Philipsen PA, et al. Pain during photodynamic therapy is associated with protoporphyrin IX fluorescence and fluence rate. Br J Dermatol. 2008;158:727–733
  62. Wiegell SR, Wulf HC. Photodynamic therapy of acne vulgaris using 5-aminolevulinic acid versus methyl aminolevulinate. J Am Acad Dermatol. 2006;54:647–651
  63. Kasche A, Luderschmidt S, Ring J, et al. Photodynamic therapy induces less pain in patients treated with methyl aminolevulinate compared to aminolevulinic acid. J Drugs Dermatol. 2006;5:353–356
  64. Kuijpers DI, Thissen MR, Thissen CA, et al. Similar effectiveness of methyl aminolevulinate and 5-aminolevulinate in topical photodynamic therapy for nodular basal cell carcinoma. J Drugs Dermatol. 2006;5:642–645
  65. Moloney FJ, Collins P. Randomized, double-blind, prospective study to compare topical 5-aminolaevulinic acid methylester with topical 5-aminolaevulinic acid photodynamic therapy for extensive scalp actinic keratoses. Br J Dermatol. 2007;157:87–91
  66. Schleier P, Berndt A, Kolossa S, et al. Comparison of aminolevulinic acid (ALA)-thermogel-PDT with methyl-ALA-thermogel-PDT in basal cell carcinoma. Photodiagnosis Photodyn Ther. 2007;4:197–201
  67. Horfelt C, Funk J, Frohm-Nilsson M, et al. Topical methyl aminolaevulinate photodynamic therapy for treatment of facial acne vulgaris: results of a randomized, controlled study. Br J Dermatol. 2006;155:608–613
  68. Babilas P, Kohl E, Maisch T, et al. In vitro and in vivo comparison of two different light sources for topical photodynamic therapy. Br J Dermatol. 2006;154:712–718
  69. Babilas P, Travnick R, Werner A, et al. Split-face study using two different light sources for topical PDT of actinic keratoses: non-inferiority of the LED system. J Dtsch Dermatol Gest. 2008;6:25–32
  70. Fritsch C, Stege H, Saalmann G, et al. Green light is effective and less painful than red light in photodynamic therapy of facial solar keratoses. Photodermatol Photoimmunol Photomed. 1997;13:181–185
  71. Morton CA, Whitehurst C, Moore JV, et al. Comparison of red and green light in the treatment of Bowen's disease by photodynamic therapy. Br J Dermatol. 2000;143:767–772
  72. Radakovic-Fijan S, Belcha-Thalhammer U, Kittler H, et al. Efficacy of 3 different light doses in the treatment of actinic keratosis with 5-aminolevulinic acid photodynamic therapy: a randomized, observer-blinded, intrapatient, comparison study. J Am Acad Dermatol. 2005;53:823–827
  73. Langmack K, Mehta R, Twyman P, et al. Topical photodynamic therapy at low fluence rates – theory and practice. J Photochem Photobiol B Biol. 2001;60:37–43
  74. Cottrell WJ, Paquette AD, Keymel KR, et al. Irradiance-dependent photobleaching and pain in δ-aminolevulinic acid-photodynamic therapy of superficial basal cell carcinomas. Clin Cancer Res. 2008;14:4475–4483
  75. Wiegell SR, Haedersdal M, Wulf HC. Cold water and pauses in illumination reduces pain during photodynamic therapy: a randomized clinical study. Acta Derm Venereol. 2009;89:145–149
  76. Pagliaro J, Elliot T, Bulsara M, et al. Cold air analgesia in photodynamic therapy of basal cell carcinomas as Bowen's disease: an effective addition to treatment. A pilot study. Dermatol Surg. 2004;30:63–66
  77. Holmes MV, Dawe RS, Ferguson J, et al. A randomized, double-blind, placebo-controlled study of the efficacy of tetracaine gel (Ametop®) for pain relief during topical photodynamic therapy. Br J Dermatol. 2004;150:337–340
  78. Langan SM, Collins P. Randomized, double-blind, placebo-controlled prospective study of the efficacy of topical anaesthesia with a eutetic mixture of lignocaine 2.5% and prilocaine 2.5% for topical 5-aminolaevulinic acid-photodynamic therapy for extensive scalp actinic keratoses. Br J Dermatol. 2006;154:146–149
  79. Skiveren J, Haedersdal M, Philipsen PA, et al. Morphine gel 0.3% does not relieve pain during photodynamic therapy: a randomized, double-blind, placebo-controlled study. Acta Derm Venereol. 2006;86:409–411
  80. Halldin CB, Paoli J, Sandberg C, et al. Transcutaneous electrical nerve stimulation for pain relief during photodynamic therapy. Acta Derm Venereol. 2008;88:311–313
  81. Borelli C, Herzinger T, Merk K, et al. Effect of cutaneous infiltration anaesthesia on pain in photodynamic therapy: a controlled open pilot trial. Dermatol Surg. 2007;33:314–318
  82. Paoli J, Halldin C, Ericson MB, et al. Nerve blocks provide effective pain relief during photodynamic therapy for extensive facial actinic keratoses. Clin Exp Dermatol. 2008;33:559–564
  83. Halldin CB, Paoli J, Sandberg C, et al. Nerve blocks enable adequate pain relief during topical photodynamic therapy of field cancerization on the forehead and scalp. Br J Dermatol. 2009;160:795–800
  84. Fritsch C, Ruzicka T. Fluorescence diagnosis and photodynamic therapy in dermatology from experimental state to clinic standard methods. J Environ Pathol Toxicol Oncol. 2006;25:425–440
  85. Ibbotson SH. Topical 5-aminolaevulinic acid photodynamic therapy for the treatment of skin conditions other than non-melanoma skin cancer. Br J Dermatol. 2002;146:178–188
  86. Taylor MN, Gonzalez ML. The practicalities of photodynamic therapy in acne vulgaris. Br J Dermatol. 2009;160:1140–1148
  87. Horfelt C, Stenquist B, Halldin CB, et al. Single low-dose red light is as efficacious as methyl-aminolevulinate-photodynamic therapy for treatment of acne: clinical assessment and fluorescence monitoring. Acta Derm Venereol. 2009;89:372–378
  88. Haedersdal M, Togsverd-Bo K, Wiegell SR, et al. Long-pulsed dye laser versus laser-assisted photodynamic therapy for acne vulgaris: a randomized controlled trial. J Am Acad Dermatol. 2008;58:387–394
  89. Haedersdal M, Togsverd-Bo K, Wulf HC. Evidence-based review of lasers, light sources and photodynamic therapy in the treatment of acne vulgaris. J Eur Acad Derm Venereol. 2008;22:267–278
  90. Fauteck J-D, Ackermann G, Birkel M, et al. Fluorescence characteristics and pharmacokinetic properties of a novel self-adhesive 5-ALA patch for photodynamic therapy of actinic keratoses. Arch Dermatol Res. 2008;300:53–60
  91. Zawislak A, Donnelly RF, McCluggage WG, et al. Clinical and immunohistochemical assessment of vulval intraepithelial neoplasia following photodynamic therapy using a novel bioadhesive patch-type system loaded with 5-aminolevulinic acid. Photodiag Photodynam Ther. 2009;6:28–40
  92. Donnelly RF, McCarron PA, AL-Kassas R, et al. Influence of formulation factors in PpIX production and photodynamic action of novel ALA-loaded microparticles. Biopharm Drug Dispos. 2009;30:55–70
  93. Donnelly RF, Morrow DI, MCarron PA, et al. Microneedle arrays permit enhanced intradermal delivery of a performed photosensitizer. Photochem Photobiol. 2009;85:195–204

☆ This is the text of the presentation by the author, as an Invited Speaker, at EPPM-2 Wroclaw September 2009.

PII: S1572-1000(09)00164-1

doi: 10.1016/j.pdpdt.2009.12.001

Photodiagnosis and Photodynamic Therapy
Volume 7, Issue 1 , Pages 16-23 , March 2010

Article Tools

* Image Usage & Resolution